Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**Phosphatidylinositol-4-phosphate 5-kinase type 1 pseudogene 2 (PIP5K1P2)** is a pseudogene in the human genome. Unlike functional kinases such as phosphatidylinositol-4-phosphate 5-kinase type 1 alpha (PIP5K1A), it does not encode an active enzyme or protein product and therefore does not play a direct biological or therapeutic role[6]. As a pseudogene, PIP5K1P2 is generally considered non-functional and is not a therapeutic target in disease or drug development. PIP5K1P2 should not be confused with the functional kinase genes in this family, such as PIP5K1A, PIP5K1B, or PIP5K1C, which are lipid kinases involved in phosphoinositide metabolism and are true therapeutic targets in a variety of signaling pathways[4][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphatidylinositol-4-phosphate 5-kinase type 1 pseudogene 2 (PIP5K1P2).